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Background: Transanal endoscopic microsurgery as a local therapy option for rectal neoplasms is a tissue-sparing
technique that protects the anal sphincter. The present retrospective analysis reports the course of observation after
local excision of adenomas and T1 low-risk carcinomas using transanal endoscopic microsurgery.
Methods: In a retrospective analysis we examined data on 279 patients for local recurrence. A total of 144 patients
had a rectal adenoma (n = 103) or a R0 resection of low-risk T1 carcinomas (n = 41). In this collective, we also
examined parameters concerning perioperative management, complications, intraoperative blood loss and duration
of hospital stay.
Results: Patients with adenoma were on average 64.9 (range 37 to 90) years old; 83.5% of the adenomas were
located 3 to 11 cm from the anocutaneous line. In adenoma patients the recurrence rate was 2.9% for an
observation period of 21.8 months. The postoperative course was without any complications in 98.1% of patients.
Patients with T1 low-risk carcinoma were 64.6 (range 30 to 89) years old. In all cases, an R0 resection could be
performed. The recurrence rate was 9.8% for an observation period of 34.4 months. In this group the postoperative
course was free of complications in 97.6% of patients.
Conclusions: The high efficacy of transanal endoscopic microsurgery ensures minimally invasive treatment of
adenomas and low-risk T1 carcinomas with low complication rates and a low rate of therapeutic failure.
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The incidence rate of colorectal cancer in Europe is
about 0.00025% a year; 29% of these carcinomas are
located in the rectum [1].
Autopsy studies reveal that 34 to 36.9% of men and
28.7 to 32% of women have rectal adenomas [2,3].
Technological progress offers new possibilities for the
surgical treatment of rectal neoplasms. There are differ-
ent local excision techniques such as the methods of
Mason and Parks [4,5]. Also, endoscopic polypectomy or
endoscopic submucosal dissection (ESD) is used in
clinical daily routine with a high rate of en bloc resec-* Correspondence: amodabber@ukaachen.de
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reproduction in any medium, provided the ortion and curative rates [6-8]. ESD offers a newer, safe
opportunity in the surgical treatment of tumors with
diameter >20 mm. The high rate of perforations can be
managed in most cases by conservative endoscopic
treatment [8]. Several studies have shown that transa-
nal endoscopic microsurgery (TEM) is a very suitable
method for surgical treatment of broad-based aden-
omas [9-13].
The literature reports the recurrence rate for transanal
polypectomy using Parks’ method to be between 16 and
20% [14,15]. In 5% a revision operation is necessary
because of complications [16]. A recrudescence rate of
3.3% is reported for the Mason method [14], with a
morbidity rate of 30.7% because of fistulas and bleeding
[17]. However, a high degree of wound infections,
fistulas and a high mortality rate are reported for these
methods [18]. A comparative study showed TEM to beLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Clinical staging of Mason
Stage Definition Pathological correlation
Clinical Stage 0 No rough parts of tumor
Clinical Stage I Freely mobile Submucosa
Clinical Stage II Mobile Muscularis propria
Clinical Stage III Tethered mobility Perirectal fat
Clinical Stage IV Fixed/tethered fixation Adjacent structures
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shorter duration of hospital stay than the Mason method
[19]. Moreover, a reduced complication and recurrence
rate is reported for TEM as compared with direct local
excision [20]. Last but not least, TEM is significantly
less expensive than local excision or anterior resection
of adenoma [20].
The literature on treatment of T1 carcinomas with
low-risk histology states that when taking account of all
relevant factors such as treatment costs, complication
rates and mortality, TEM with continuous follow-up
examinations is superior to the radical methods [19,21].
An important factor in T1 carcinomas is the differenti-
ation between low-risk and high-risk histology. Now-
adays tumors are classified in sm-stadiums sm1 to sm3
according to their depth of submucosal penetration.
Patients with sm2 to sm3 are high-risk cases for treat-
ment with TEM alone [22]. Our patient collective dates
from a time before this classification were established.
Our collective, called T1 low-risk carcinomas, includes
T1 carcinomas with histological grading G1 to G2, R0
resection and the absence of microlymphatic or micro-
vascular invasion.
The aim of this retrospective analysis is to show that
TEM is a safe, minimally invasive technique with a low
recurrence rate for the treatment of rectal adenomas
and T1 carcinomas with low-risk histology (histological
grading G1 to G2, R0 resection and the absence of
microlymphatic or microvascular invasion).
Patients and methods
Patients
Overall 279 patients with rectal neoplasm had a local
excision with TEM in our sections in the Olympiapark-Figure 1 Clinical staging of the preoperatively performed digital examKlinik Munich and the Helios-Klinik Müllheim between
1998 and 2006. The patients signed written informed
consent forms concerning the potential surgical risks.
Out of this group, data for 144 patients with rectal aden-
oma (n = 103) and low-risk T1 carcinoma (n = 41) were
retrospectively evaluated for local recurrence. The rest
of our collective (n = 135) had advanced stages of rectal
carcinomas. These patients were treated by TEM because
of multimorbidity, older age or because they avoided a
radical surgical procedure. This subgroup is excluded from
the present study.
The primary endpoint of the study was the recurrence
rate of adenoma or carcinoma in all study patients
who underwent continuous follow-up examinations
including, among others, rectoscopy and endoscopic
ultrasonography.
The collected data were analyzed with the database
management system Microsoft Access 2003 (Microsoft
Corporation, Redmond, WA, USA). The database docu-
mented tumor characteristics such as size, pathology
and distance from the anocutaneous line. We collected
data on the applied excision method, intraoperative
blood loss, operation time, perioperative complications
and duration of hospital stay.
Surgical procedure
Before surgery, physical examination with digital rectal pal-
pation, rectoscopy and endosonography for the localization
and extent of the tumor were performed in all patients. In
addition, preoperative histology with biopsy forceps was
performed.
Patients with adenomas and T1 low–risk histology
(pathologic findings (G1 to G2), R0 resection and the
absence of microlymphatic or microvascular invasion)
were included.
All patients underwent surgery using the TEM technique,
which was described for the first time by Buess and collea-
gues [9,23]. Surgery was performed on the operating table
using a fixed, wide-lumen rectoscope. Complex microsurgi-
cal instruments including lenses providing a three-dimen-
sional view were introduced through the rectoscope. The
TEM instrument set used was obtained from Richard Wolf
GmbH (Knittlingen, Germany). A full-thickness intestinalination in the adenoma group.
Figure 2 Results of the endosonographic ultrasound examination in the adenoma group.
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anocutaneous line in the dorsal area. Because of the risk
of perforation, a partial-thickness excision of the intes-




The group of patients with adenoma included 103
patients, 57 patients were female and 46 male. The mean
age was 64.9 (range 37 to 90) years, median 65 years. Of
the patients, 83.5% preoperatively reported being symp-
tom free, 9.7% consulted a physician because of bloody
stools, 4.9% because of bloody mucus, while 1.9% had
other symptoms.
Digital rectal palpation was classified according to the
modified clinical staging of Mason [24] (Table 1). The
results of digital examination are shown in Figure 1 and
the results of preoperatively performed endosonographic
findings in Figure 2.
Preoperative histological findings showed in 60% of
the study patients a nonhigh-grade adenoma, and in
40% a high-grade adenoma (Figure 3). In the final histo-
logical evaluation following TEM, 51 patients had a
nonhigh-grade adenoma and 52 patients a high-grade
adenoma.
Tumor distance was measured from the lower rim of
the tumor to the anocutaneous line. Of the adenomas
83.5% were located 3 to 11 cm from the anocutaneousFigure 3 Preoperative histological findings in the adenoma group.line, while most (37.9%) of them were at a distance of 6
to 8 cm and 16.5% were situated >11 cm from the
anocutaneous line.
Full-thickness excision of the intestinal wall was per-
formed in 87.4% of patients, while 12.6% of the patients
underwent partial-thickness excision of the intestinal
wall to avoid perforation to the abdominal cavity. Intrao-
perative blood loss averaged 20.6 (range 5 to 100) ml. In
the adenoma group we had no severe intraoperative
complications such as perforation or uncontrolled
bleeding.
The postoperative course was without complications
in 101 (98.1%) patients. In two cases a rectal stenosis
was postoperatively observed by endoscopy; it was over-
come with a rectoscope and treated with stool-regulatory
measures. Duration of hospital stay after surgery was
on average 8.8 (range 1 to 18) days. Twenty-four of
103 patients (23.3%) had a tumor size ≤3 cm. Fifty-four
patients (52.4%) had a tumor diameter >3 cm, with a
maximum of 5 cm. A tumor diameter >5 cm with a max-
imum of 7 cm occurred in 17 patients (16.5%). In eight
patients the tumor diameter was even larger than 7 cm.
After a follow-up period of 21.8 months, 96 (93.2%)
patients were free of recurrence with a follow-up rate
of 96.1% (Table 2). Three patients relapsed after local
excision with TEM. All of them had a re-TEM and they
were relapse free until the end of the observation
period. Figure 4 illustrates the Kaplan–Meier curve for
the probability of relapse-free time.
Table 2 Follow-up of the adenoma group
Nonhigh-grade High-grade Overall
n 51 52 103
Recurrence free (n) 47 49 96
Lost to follow-up (n) 1 3 4




Mean duration of observation
period (months)
20.7 22.9 21.8
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The group of patients with low-risk T1 carcinoma
included 41 patients (16 female, 25 male). The mean age
was 64.6 (range 30 to 89) years, median 65 years.
Before surgery 62.1% of the patients were symptom
free, 23.3% reported bloody stools and 6.8% mucus as
the initial symptom, while 7.8% indicated other symp-
toms such as stool irregularity. The results of digital
rectal palpation according to the Clinical Staging of
Mason are shown in Figure 5. Preoperative endosono-
graphic and histological findings are shown in Figures 6
and 7.
In 13 of 41 T1 low-risk carcinoma findings, preoperative
histological examination showed adenomas (32.0%). Con-
sistent with preoperative histological findings, 28 (68.0%)
patients had a T1 low-risk carcinoma. As in patients with
adenoma, 83.3% of T1 carcinomas were located 3 to 11 cm
from the anocutaneous line, whereby most (39.8%) of the
carcinomas were at a distance of 6 to 8 cm; 16.7% were
more than 11 cm from the anocutaneous line.
In 89.3% of our cases a full-thickness excision of the
intestinal wall was performed, and 10.7% of the studyFigure 4 Kaplan–Meier curve for the probability of relapse-free timepatients were treated with a partial-thickness excision of
the intestinal wall.
Average intraoperative blood loss was 57.7 ml, median
10 (range 5 to 1,500) ml. Most of the patients (40 of 41
patients) had no severe intraoperative complications. In
one patient, uncontrolled intraoperative bleeding caused
delayed hemostasis and blood transfusion was necessary.
The postoperative course was without complication in 40
out of 41 patients. In one patient, a suture insufficiency
occurred during hospitalization. This was diagnosed by
control rectoscopy and treated conservatively. Postoperative
hospital stay averaged 10.0 (range 4 to 23) days.
In seven out of 41 patients (17.1%) the tumor size was
≤3 cm. Twenty-three of 41 patients (56.1%) had a tumor
size >3 cm with a maximum of 5 cm. Eleven patients
(26.8%) even had a tumor size larger than 5 cm.
Therapy consisted exclusively of local excision by
means of TEM. In all 41 patients an R0 resection was
performed; 35 of these patients underwent regular
follow-up without recurrence or complaints. Histological
findings showed T1 low-risk carcinomas (G1 to G2, L0,
V0) with a follow-up rate of 95.1%. Only two patients
were lost to follow-up. Thirty-five (85.4%) patients were
recurrence free.
Four patients relapsed after 13 to 71 months (Table 3).
All of them had an initial tumor size >3 cm and two of
them had a partial-thickness excision.
Two patients were given adjuvant radiochemotherapy
and re-TEM, subsequently remaining relapse-free for 35
and 39 months, respectively. The third patient relapsed
after 30 months and was operated with curative intent
using a deep anterior rectal resection to preserve the
sphincter. This was followed by adjuvant radiochemother-
apy. In the fourth patient, relapse was diagnosed 71 monthsof adenomas.
Figure 5 Clinical staging of the preoperatively performed digital examination in the T1 carcinoma group.
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rence and liver metastases. The patient subsequently under-
went palliative radiochemotherapy.
Average relapse-free survival was 29.5 months with a
median of 25 months. Average duration of the observa-
tion period was 34.4 months, median 27 months.
The overall recurrence rate in patients with T1 low-risk
carcinoma was 9.8%. Of the relapsed patients, 75% under-
went curative treatment.
The rate of failure was thus 2.4%. Figure 8 shows the
Kaplan–Meier curve for the probability of relapse-free time.
Discussion
The study collective was analyzed retrospectively.
Patients with histologically determined adenomas and
T1 low-risk carcinomas were included. When planning
optimal treatment of rectal neoplasms, preoperative as-
sessment of tumor extension should be as accurate as
possible. All patients in this study collective underwent
rectoscopy, digital rectal examination, transrectal endoso-
nography and biopsy, among other diagnostic procedures.
Adenomas were retrospectively classified as uT0 in
52% of patients, uT1 in 46%, and uT2 in 2% (Figure 2).
On the other hand, T1 low-risk carcinomas were classi-
fied as uT0 in 27% of patients, uT1 in 66% and uT2 in
7% (Figure 6). Ashraf and colleagues reported the accur-
acy of endorectal ultrasound to be disappointing for pre-
operative staging [25]. Zorcolo and colleagues alsoFigure 6 Results of the endosonographic ultrasound examination in tconfirmed that differentiation between T0 and T1 with
endorectal ultrasound remains a challenge, even though
it does not influence surgical strategy [26].
In the group of patients with adenoma, preoperative
histology already pointed to an adenoma in each patient
(Figure 3). In this study the preoperative histology of
patients in the T1 low-risk carcinoma group already
showed a low-risk carcinoma in 68.0% of patients. In
32% the biopsy showed an adenoma (Figure 7). This
confirms the limited accuracy of preoperative biopsy,
as mentioned in the literature [27].
Transrectal ultrasound showed stage uT0/uT1 in 101
(98.1%) of the 103 patients in the adenoma group.
Digital rectal palpation classified 52.4% (54/103) of the
patients as Clinical Stage 0 and another 35.9% (37/103)
as Clinical Stage 1. The biopsy for each patient showed
an adenoma.
For T1 low-risk carcinomas, digital–rectal palpation
showed a Clinical Stage 1 carcinoma in 50.5% of patients.
Transrectal ultrasound showed stage uT0/uT1 in 38/41
(92.%) patients. As mentioned, preoperative histology
showed a low-risk carcinoma in 68% of patients.
Two percent of adenomas and 7% of carcinomas were
tagged uT2 at the preoperative endosonographic exam-
ination. TEM was offered to these patients as a curative
therapeutic option because there is no statistical differ-
ence in the 5-year survival rate between TEM and
radical surgery for T2 carcinomas [28].he T1 carcinoma group.
Figure 7 Preoperative histological findings in the T1 carcinoma group.
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of examinations can provide the most accurate tumor
assessment. This information can be used for surgical
planning and for the differentiation between adenomas
and T1 low-risk carcinomas. Our study population
showed a perioperative mortality rate and a rate of ost-
omy pouch of 0%. These known advantages of TEM,
particularly as compared with the radical surgical pro-
cedure, were confirmed by our study [29]. Moreover, this
study performed in a larger collective confirms that
TEM-induced lesser blood loss decreases postoperative
risk [12] and also confirms the shortened duration of
hospital stay following local excision [30]. This is very
important, especially from a financial point of view. In
our collective the average hospital stay is long compared
with the hospital stay after TEM. Some of our patients
had local excision in 1998 when our experiences about
TEM and postoperative complications were lower. For
example, in 2006 our average hospital stay was much
shorter compared with 1998 (5.7 days vs. 11.8 days).
The 103 adenoma patients showed a recurrence rate
of 2.9% in an average observation period of 21.8 months.
This correlates with data reported to date in the litera-
ture, namely recurrence rates of 2.2 to 16% for adenomas
following local excision. TEM is therefore described as
an appropriate method for treating broad-based rectal
adenomas [10-12]; the results of our study confirm this




Recurrence free (n) 35
Lost to follow-up 2
Recurrences (n) 4
Mean relapse-free survival (months) 29.5
Mean duration of observation period (months) 34.4A novel procedure that also enables resection of early
rectal neoplasm is ESD. Some comparative studies have
shown that ESD offers better short-term clinical out-
comes with shorter hospital stay than a local excision
approach [6,31]. Nevertheless, larger studies are needed
to validate the clinical long-term outcome. A compara-
tive study concerning the effectiveness of ESD with
conventional endoscopic mucosal resection for tumors
>20 mm diameter reveals that ESD has a longer pro-
cedure time and higher perforation rate but higher en
bloc resection and curative rates compared with the
conventional endoscopic mucosal resection [7,8]. By
conservative endoscopic treatment, the perforations
after ESD could be managed [8]. The role of TEM in
the treatment of tumors with diameter >20 mm
therefore nowadays has minor clinical importance
since the introduction of ESD into the clinical daily
routine.
The superiority of TEM versus total mesorectal exci-
sion in the treatment of T1 carcinomas is the subject of
debate in the literature. Lezoche and colleagues reported
that long-term results after local excision using TEM are
not inferior to those reported for total mesorectal excision
[32]. A comparative study for T1 carcinomas showed TEM
to be much safer, survival being comparable with that of
total mesorectal excision [33].
In our sample the recurrence rate for patients with
T1 low-risk carcinoma was 9.8% for an average obser-
vation period of 34.4 months. A limitation of this
study is the fact that the depth of submucosal pene-
tration of T1 low-risk carcinoma was not determined
in our collective, because it is an important prognostic
risk factor for recurrence [22]. Doornebosch and
colleagues showed that tumor size alone is also a
significant predictive factor for locoregional failure
after TEM for T1 rectal cancer. Local recurrence
rates at 3 years for T1 tumors with diameter ≤3 cm
were significantly lower [34]. In our results all
Figure 8 Kaplan–Meier curve for the probability of relapse-free time of T1 low-risk carcinomas.
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>5 cm. Also in two of four patients with recurrence
only a partial excision was performed.
Even though the recurrence rate in our collective is
relatively high (9.8%), the rate of failure observed in
this collective was 2.4%. This observation implies that
97.6% of the study patients remained recurrence free
or were successfully treated after relapse. These data
demonstrate that TEM is a curative surgical technique.
After relapse the therapeutic trial with TEM was not
a disadvantage with regard to the prognosis in three of
four cases. Particularly important in this context are
continuous follow-up examinations, because 75% of
the patients in this study in whom a relapse was diag-
nosed early were successfully treated. The different ap-
proach in therapy after relapse is caused in different
wishes of patients and concomitant diseases. Two
patients were given radiochemotherapy and re-TEM
after relapse. A radical surgical procedure was rejected
by the patients because of multimorbidity.
Taking these data and the reduced surgical trauma,
TEM provides an adequate primary method for treat-
ment in this tumor stage. This finding is consistent
with the experiences described by other authors for
treatment of early rectal cancer [12,21]. Moreover,
the fact that patients who suffer a relapse can still be
successfully treated is also described in the literature
[21]. Nevertheless, the indication spectrum of TEM
in clinical daily routine has become smaller since the
introduction of ESD.Conclusions
Our results confirm that TEM is an appropriate method
for treating broad-based rectal adenomas. For T1 low-
risk carcinomas TEM offers a therapeutic option withlow complication rates and a low rate of therapeutic
failure.
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